FDA Inspection 1154808 — David J. Warrow, M.D.
The FDA completed an inspection of David J. Warrow, M.D. on Oct 1, 2021 in Hagerstown, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 1, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hagerstown, MD (United States)
Additional Details
Clinical Investigator (CI)